Pfizer finalizes $2.3 bln Bextra settlement - MarketWatch

BBCIndonesia.comPfizer finalizes $2.3 bln Bextra settlementMarketWatchSAN FRANCISCO (marketwatch) -- Pfizer Inc. said it finalized a $2.3 billion settlement over marketing the drug Bextra for unapproved uses. ...Bextra Whistleblower Case Started Investigation of PfizerReutersPfizer To Pay $2.3B To Settle Case On Drug Marketing - DOJWall Street JournalPfizer Agrees to Record Criminal Fine in Fraud ProbeBloombergWall Street Journal Blogs -MarketWatch -Reutersall 1,286 news articles »